PCA
XRAY icon

Providence Capital Advisors’s Dentsply Sirona XRAY Stock Holding History

Providence Capital Advisors’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-60
Closed -$3K – 346
2020
Q4 		$3K Buy
+60
New +$2.96K ﹤0.01% 290
2018
Q4 		– Sell
-100
Closed -$3.64K – 274
2018
Q3 		$4K Hold
100
– – ﹤0.01% 239
2018
Q2 		$4K Hold
100
– – ﹤0.01% 234
2018
Q1 		$5K Hold
100
– – ﹤0.01% 224
2017
Q4 		$7K Buy
+100
New +$6.36K 0.01% 237

Other funds holding XRAY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Providence Capital Advisors's XRAY Position: Q1 2021 in Review

Providence Capital Advisors sold out of Dentsply Sirona (XRAY) in Q1 2021, closing a stake of 60 shares — an estimated $3K sold.

Providence Capital Advisors first reported a position in XRAY in Q4 2017 and held it in 5 quarters. The position peaked at $7K in Q4 2017. 540 funds tracked by Wall St. Rank hold XRAY as of Q1 2021.

  • Providence Capital Advisors reported no remaining Dentsply Sirona position as of Q1 2021 after selling out during the quarter.
  • Providence Capital Advisors sold 60 Dentsply Sirona shares in Q1 2021, an estimated $3K.
  • Providence Capital Advisors first reported a position in Dentsply Sirona in Q4 2017 and held it in 5 quarters.
  • Providence Capital Advisors's Dentsply Sirona position peaked at $7K in Q4 2017.
  • 540 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2021.

Based on Providence Capital Advisors's 13F filing for Q1 2021, filed 13 May 2021.